Literature DB >> 3605049

Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.

J B Croft, D S Freedman, J L Cresanta, S R Srinivasan, G L Burke, S M Hunter, L S Webber, C G Smoak, G S Berenson.   

Abstract

Risk factors for cardiovascular disease were measured in 990 young adults, aged 17-24 years, in a 1982-1983 survey of the biracial (black-white) community of Bogalusa, Louisiana. Even after controlling for age and obesity, several lifestyle factors (cigarette smoking, alcohol consumption, and oral contraceptive use) were independently related (p less than 0.05) to levels of serum lipids, lipoprotein cholesterol fractions, and blood pressure. Oral contraceptive use was associated with increased levels of both serum triglycerides (20 mg/dl, blacks; 25 mg/dl, whites) and low density lipoprotein (LDL) cholesterol (19 mg/dl, whites), and decreased levels of high density lipoprotein (HDL) cholesterol (-6 mg/dl, whites). Linear regression analyses also showed that cigarette smoking was associated with elevated levels of serum triglycerides (ranging from 15 to 26 mg/dl) and decreased levels of HDL cholesterol (ranging from -9 to -11 mg/dl) in white males and females. Although persons who smoked cigarettes were also likely to consume alcohol, alcohol intake in nonsmokers was positively associated with levels of serum triglycerides, LDL cholesterol, and very low density lipoprotein cholesterol in white males, and with blood pressure levels in black males. A statistically significant association between alcohol intake and HDL cholesterol levels (r = 0.24) was observed only in white females who did not smoke. These adverse influences of lifestyle factors on cardiovascular disease risk may provide a rational basis for intervention during adolescence and early adulthood.

Entities:  

Keywords:  Adolescents; Age Distribution; Age Factors; Alcohol Drinking--side effects; Americas; Anthropometry; Behavior; Biology; Blood Pressure; Cardiovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Cultural Background; Demographic Factors; Developed Countries; Developing Countries; Diseases; Ethnic Groups; Examinations And Diagnoses; Family Planning; Hemic System; Laboratory Examinations And Diagnoses; Laboratory Procedures; Life Style; Lipid Metabolic Effects; Lipids; Louisiana; Measurement; Metabolic Effects; North America; Northern America; Oral Contraceptives--side effects; Physiology; Population; Population At Risk; Population Characteristics; Research Methodology; Sex Distribution; Sex Factors; Smoking--side effects; Social Behavior; United States; Youth

Mesh:

Substances:

Year:  1987        PMID: 3605049     DOI: 10.1093/aje/126.2.202

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  4 in total

1.  Do long-term HDL-C declines associated with a first birth vary by apo E phenotype? The Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Erica P Gunderson; Rachel A Whitmer; Cora E Lewis; Charles P Quesenberry; Delia Smith West; Stephen Sidney
Journal:  J Womens Health (Larchmt)       Date:  2005-12       Impact factor: 2.681

2.  Long-term effects of oral contraceptives on the prevalence of diabetes in post-menopausal women: 2007-2012 KNHANES.

Authors:  Sung-Woo Kim; Jae-Han Jeon; Won-Kee Lee; Sungwoo Lee; Jung-Guk Kim; In-Kyu Lee; Keun-Gyu Park
Journal:  Endocrine       Date:  2016-05-09       Impact factor: 3.633

3.  Correlates of high-density lipoprotein cholesterol in Black girls and White girls: the NHLBI Growth and Health Study.

Authors:  J A Simon; J A Morrison; S L Similo; R P McMahon; G B Schreiber
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

4.  Alcohol consumption among adolescents and young adults: the Bogalusa Heart Study, 1981 to 1991.

Authors:  C C Johnson; L Myers; L S Webber; S M Hunter; S R Srinivasan; G S Berenson
Journal:  Am J Public Health       Date:  1995-07       Impact factor: 9.308

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.